AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04595370 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Description: Participants will receive dapagliflozin as per the arms they are randomized.
Study NCT04569097 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: standard of care lingual strengthening
Description: standard or care lingual strengthening approaches with outcome measured with novel pressure metrics
Study NCT04933227 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Description: Atezolizumab 1200 mg will be administered intravenously (IV) on Day 1 of each 21-day cycle.
Study NCT04933227 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tiragolumab
Description: Tiragolumab 600 mg will be administered IV on Day 1 of each 21-day cycle.
Study NCT04933227 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: Oxaliplatin 130 mg/m\^2 will be administered IV on Day 1 of each 21-day cycle during Cycles 1-4.
Study NCT04933227 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Capecitabine 1000 mg/m\^2/d will be administered orally (PO) twice daily (bid) on Days 1-14 during Cycles 1-4.
Study NCT05765227 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Lehfilcon A multifocal contact lenses
Description: Investigational silicone hydrogel multifocal contact lenses
Study NCT05765227 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Lotrafilcon B multifocal contact lenses
Description: Commercially available silicone hydrogel multifocal contact lenses
Study NCT05765227 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Hydrogen peroxide-based cleaning and disinfection system
Description: Commercially available cleaning and disinfection system for silicone hydrogel contact lenses
Study NCT05185011 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TPN171H
Description: 10 mg TPN171H tablets，single dose
Study NCT05124418 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: palatal masticatory mucosa thickness measurement
Description: Measure the thickness of palatal masticatory mucosa by a dynamic navigation system (Navident®, ClaroNav Inc., Toronto, Canada) and periodontal probe piercing.
Study NCT05030961 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual team-based clinic
Description: Virtual team-based clinic will include consultation, counseling, and education from pediatric audiology, psychology, auditory verbal therapy, and education. Each session lasts approximately 30 minutes with a total of 3 sessions within the year.
Study NCT05030961 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Remote cochlear implant programming
Description: Remote cochlear implant programming will be provided via Zoom on a study-provided encrypted laptop.
Study NCT05034874 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Saline
Study NCT04817579 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Digital photography combined with eLABor_aid shade analyzing software
Description: ELABor_aid is a new approach to objective shade communication and shade reproduction in dentistry, based on numeric quantification obtained from standardized RGB (red-green-blue) images, and the formulation of a patient personal shade recipe using trichromatic subtractive color mixing laws, thus abandoning the use of visual assessment and shade guides entirely. This approach is currently enjoying increasing popularity for its ease of use, reliability as well as for its practically oriented features like its imaging ability or the digital try-in.
Study NCT04817579 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Spectrophotometer
Description: Spectrophotometric measurement methods employing computer calculations, based on color science and theories, allow quantitative evaluation which is objective and appears to be more accurate.
Study NCT04817579 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional visual shade matching
Description: Visual shade matching is the most common method, in which a color standard from a commercially available dental shade guide is compared to and matched with the target tooth.
Study NCT06034275 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VIP943 (QW)
Description: VIP943 will be administered by IV Infusion weekly
Study NCT06034275 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VIP943 (BIW)
Description: VIP943 will be administered by IV Infusion bi-weekly
Study NCT05391763 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Fascia pectoralis preservation
Description: A total mastectomy will be performed in the control breast: a procedure which includes removal of the breast glandular tissue including the PF and subcutaneously excision of the nipple-areolar complex, while the pectoralis muscle will be spared. As much of the healthy skin envelope will be preserved to enable the performance of an effective breast reconstruction afterwards. When a nipple-sparing mastectomy is performed, the skin envelope together with the nipple-areolar complex will be spared. The investigational part of the operation is preservation of the PF. Dissection of cutaneous flaps and the breast with or without the PF will be performed with electrocautery.
Study NCT05977725 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Hand Doppler Ultrasound
Description: Hand Doppler Ultrasound to assess the Hand Acceleration Time (HAT)
Study NCT06150144 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-Fluorouracil
Description: The invistigators want to assess the safety and efficacy of using intralesional 5-FU for the management of different types of BCC (including all the types EXCEPT the infiltrative one), by estimating different outcomes after the intralesional administration of 5-FU to BCC patient. Patients are randomly selected from the outpatient dermatologic clinic in the Aleppo University Hospital (AUH) over a period of 12 months and then these patients are followed up over another 12 months.
Study NCT06150144 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: SURGERY
Description: Total excision of the lesion
Study NCT06326970 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: 99mTc-FAPI SPECT imaging
Description: 99mTc radionuclide is labeled to a HYINC-FAPI-04 probe as a tracer. SPECT imaging was performed 2 hours after 99mTc-FAPI intravenous injection into the subject, and image processing and quantitative analysis were performed using the Q.Volumetrix MI System software package.
Study NCT04044534 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intranasal insulin
Description: Subjects in this arm will receive intranasal insulin (80 IU per day).
Study NCT04044534 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Subjects in this arm will receive placebo.
Study NCT05197101 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: balloon catheter combined with oxytocin induction
Description: Balloon catheter for 12 hours and oxytocin for up to 3days.If failed , they will be treated ceacrean.
Study NCT05767541 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pilates exercises
Description: The Pilates technique consist of hundred, swimming, prone leg lift, single leg stretch, spine stretch forward, arm circles, imprint and release, one leg circles and mini squat.
Study NCT05767541 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Resistance exercises
Description: Resistance training include leg press, shoulder press, bench press, back arm press, seated row, knee extension, leg curl and seated calf raise
Study NCT06498375 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Bioelectrical impedance
Description: Fluid distribution measured by bioelectrical impedance Bodystat Multiscan 5000 Bodystat Ltd, Isle of Man, British Isles
Study NCT04820478 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Beta Hydroxybutyrate Ester (KetoneAid KE4)
Description: see arm/group description
Study NCT04820478 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: see arm/group description
Study NCT05074745 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: ELISA POCT vs RT-PCR
Description: 3 swabs taken, buccal for RT-PCR and ELISA POCT, nasopharyngeal for RT-PCR
Study NCT05841121 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Antenatal dexamethasone will be given a course of four intramuscular injections of dexamethasone 6 mg (1.2 milliliter), 12 hours apart.
Study NCT06560827 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CT011 CAR-GPC3 T Cells Injection
Description: The dose selection for this trial was mainly based on the preliminary safety and efficacy results of CT011-HCC-01 trial in subjects with advanced HCC, in which 3 and 5 subjects in the 2.5 × 108 cell and 5.0 × 108 cell dose groups, respectively, completed a single infusion of CT011. The results showed that the two dose groups of CT011 were generally well tolerated in HCC subjects who failed to standard treatment, with controllable safety, and showed preliminary anti-tumor efficacy.
Study NCT06131463 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electrocardiogram (ECG) feature in smart watches
Description: A study participant that is randomly assigned to the experimental group should enable the ECG function on his or her smart watch and make sure that there is synchronization with a corresponding application on his or her mobile phone. The ECG function must stay enabled, and the participant should wear the smartwatch every day for 30 days.
Study NCT06386042 — intervention group
Intervention type: OTHER
Intervention: no intervention, observational study
Description: no intervention, observational registry of the prescription of medical therapy according to the European Society of Cardiology Heart Failure guidelines (quality of care).
Study NCT05198310 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KPL-404
Description: Humanized monoclonal antibody
Study NCT05198310 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo
Study NCT05198310 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching placebo
Study NCT06097806 — intervention group
Intervention type: OTHER
Intervention: low and high flow
Description: low and high flow anesthesia are both being used. The effects of different gas flows will be evaluated.
Study NCT04986527 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Chest tube suction
Description: The chest tubes will be inserted using our institutional standard chest tube insertion tray. The chest tubes used will be our institutional standard and will range from 14 to 32Fr in size. After chest tube placement, an Atrium Oasis Dry Suction Water Seal Chest Drain (Getinge USA Sales, LLC) will be used.
Study NCT04986527 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Chest tube suction
Description: The chest tubes will be inserted using our institutional standard chest tube insertion tray. The chest tubes used will be our institutional standard and will range from 14 to 32Fr in size. After chest tube placement, an Atrium Oasis Dry Suction Water Seal Chest Drain (Getinge USA Sales, LLC) will be used.
Study NCT05450068 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Mulligan's Mobilization with movement
Description: The Mulligan's technique will be performed as described by Brian Mulligan. 3 sets of 10 repetitions with 1 minute rest between sets.
Study NCT06203665 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Recruitment Maneuver
Description: The surgery would be performed under general anaesthesia according to the common practice using protective lung ventilation ( Vt= 6 ml /Kg ideal body weight , RR to maintain end-expiratory CO2 35-45 cmH2O and PEEP= 6- 8 cm H20). An incremental and decremental positive end-expiratory pressure alveolar recruitment maneuver would be performed after release of pneumoperitoneum.
Study NCT05374993 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 3TBA
Description: Induce third molar tooth bud agenesis
Study NCT05558670 — intervention group
Intervention type: OTHER
Intervention: PET-fMRI-EEG
Description: Participants perform PET, fMRI, and EEG simultaneously using a MRI compatible EEG cap
Study NCT06002061 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NovaResp MAPR System
Description: Baseline measurements will be taken while the subject is awake. Genioglossus activity with maximal tongue protrusion will be measured as well as the response to 1 to 2 pressure routines. Once the subject is sleeping, the operator will observe the PSG recording and determine sleep stage and respiratory phase (inspiration, expiration, between breaths). Test routines will be performed for each sleep stage and each respiratory phase. If the operator notices an apnea occurring, one of the routines will be applied. When all manual tests are complete, an automatic mode will be engaged for the remainder of the night. During this mode, a previously developed and trialled AI model will be used to predict if an obstructive apnea is upcoming. The operator will input which routine to test, and the routine will be automatically applied when a prediction occurs. There will be a minimum of 60 seconds between pressure routine applications.
Study NCT05255484 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LM-108
Description: Administered intravenously
Study NCT05255484 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: An Anti-PD-1 Antibody
Description: Administered intravenously
Study NCT06196047 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ticagrelor 90 MG
Description: Efficacy and safety of 180 mg loading dose of ticagrelor administered within 24 hours of first-ever ischemic stroke followed by 90 mg bid for 3 months will be assessed through NIHSS, mRS, new ischemic stroke, and possible adverse effects.
Study NCT06196047 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cilostazol 100 MG
Description: Efficacy and safety of 200 mg loading dose of cilostazol administered within 24 hours of first-ever ischemic stroke followed by 100 mg bid for 3 months will be assessed through NIHSS, mRS, new ischemic stroke, and possible adverse effects.
Study NCT05813847 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: local anaesthetic injection
Description: Local infiltration of study drug
Study NCT05618847 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Acapella,ACBTS
Description: Every subject will perform supervised ACBTs with and without acapella for four weeks. Three sessions per week will be given with 20 repetitions in two sets
Study NCT05618847 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ACBTs
Description: Every subject will perform supervised ACBTs with and without acapella for four weeks. Three sessions per week will be given with 20 repetitions in two sets
Study NCT05618847 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ACBTs
Description: Every subject will perform supervised ACBTs with and without acapella for four weeks. Three sessions per week will be given with 20 repetitions in two sets
Study NCT05835193 — intervention group
Intervention type: OTHER
Intervention: Diagnostic Test: Distance Visual Acuity Examination
Description: Best spectacle-corrected distance visual acuity and reading capacity of pre-school students in Alexandroupolis, Greece will be examined via a web-based digital visual acuity chart
Study NCT05813847 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: local anaesthetic injection
Description: Local infiltration of study drug
Study NCT05813847 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: local anaesthetic injection
Description: Local infiltration of study drug
Study NCT05194982 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BL-B01D1
Description: Administration by intravenous infusion
Study NCT05163691 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5 Methoxy N,N Dimethyltryptamine
Description: GH001 administered via inhalation
Study NCT05163691 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: GH001 Placebo administered via inhalation
Study NCT05033600 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: S.C.I.O.
Description: The devices read, emit and entrain Electromagnetic waves of the body.
Study NCT05450068 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Spencer's muscle energy technique
Description: Muscle energy technique that is composed of 7 stages repeated on after the other will be performed. Each movement will be repeated 10 times with 1 minute rest between each set.
Study NCT05450068 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Therapy
Description: Electrotherapy-Ultrasound (5-10 mins), Exercise therapy program (isometric, capsular stretching, pectoral stretch and scapular stabilization exercises)
Study NCT05850377 — intervention group
Intervention type: DRUG
Intervention: 5-Aminolevulinic Acid (5-ALA) Gliolan®
Description: Gliolan® is presented as a powder for oral solution in 60 ml colorless glass vials and is administered orally three hours (range 2-4 hours) before anaesthesia. One bottle contains 1.17 g of 5-aminolevulinic acid (5-ALA), corresponding to 1.5 g 5-aminolevulinic acid hydrochloride (5-ALA HCl). The recommended dose is 20 mg 5-ALA HCl per kilogram body weight. One ml of reconstituted solution contains 23.4 mg of 5-ALA, corresponding to 30 mg 5-ALA HCl.
Study NCT05850377 — intervention group
Intervention type: PROCEDURE
Intervention: Fluorescence-Guided Surgery using 5-aminolevulinic acid (5-ALA)
Description: During the surgical exploration of the glioma, the neurosurgeon will attempt to identify the mass. The location of the tumor will be assessed using the blue-light filtered microscope. A biopsy of the fluorescent region will be taken to confirm the glioma subtype. The tumor will then be maximally resected.
Study NCT05025540 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: ultrasonic imaging
Description: Two-dimensional ultrasound images of the patient's kidneys were obtained by ultrasound imaging.
Study NCT05858333 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Extended culture for Group 2: (day 3-5 group)
Description: To investigate thawing day three embryos and culturing them to be transferred as blastocyst that will improve pregnancy rate when compared to transfer thawed frozen blastocyst.
Study NCT06423014 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Wearable devices only
Description: self-monitoring
Study NCT06423014 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Wearable devices only
Description: self-monitoring
Study NCT06423014 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Wearable devices with the 1st behavior change technique
Description: reminder
Study NCT06423014 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Wearable devices with the 2nd behavior change technique
Description: social support
Study NCT06423014 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Wearable devices with the 3rd behavior change technique
Description: Competition
Study NCT06423014 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Wearable devices with the 4th behavior change technique
Description: Goal-setting
Study NCT06423014 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Wearable devices with the 5th behavior change technique
Description: health coach
Study NCT06423014 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Wearable devices with all behavior change techniques
Description: Self-monitoring, health coach, goal-setting, competition, social support, and reminder
Study NCT06423014 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Wearable devices with all behavior change techniques
Description: Self-monitoring, health coach, goal-setting, competition, social support, and reminder
Study NCT06477328 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Telemedicine
Description: Video calls were made with the telemedicine group.
Study NCT06335147 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Serplulimab, mFOLFOX6
Description: Serplulimab，200mg，iv，q2w，d1； mFOLFOX6（Oxaliplatin: 85 mg/m2，LV ：400mg/m2，Fluorouracil： 400mg/m2 d1，2400 mg/m2 continuous intravenous drip for 46-48 hours；q2w）
Study NCT05508594 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CT001
Description: Intranasal
Study NCT05554146 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Receipt of Coupon for Placebo Soft-Gel Capsule
Description: The investigators will follow participants who were randomized to receive a coupon for placebo soft-gel capsule medical cannabis products by our collaborators at Vireo medical cannabis dispensary in a separate study
Study NCT05554146 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Receipt of Coupon for High THC Soft-Gel Capsule
Description: The investigators will follow participants who were randomized to receive a coupon for high THC soft-gel capsule medical cannabis products by our collaborators at Vireo medical cannabis dispensary in a separate study
Study NCT05554146 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Receipt of Coupon for Equal THC and CBD Soft-Gel Capsule
Description: The investigators will follow participants who were randomized to receive a coupon for equal THC and CBD soft-gel capsule medical cannabis products by our collaborators at Vireo medical cannabis dispensary in a separate study
Study NCT05554146 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Receipt of Coupon for High CBD Soft-Gel Capsule
Description: The investigators will follow participants who were randomized to receive a coupon for high CBD soft-gel capsule medical cannabis products by our collaborators at Vireo medical cannabis dispensary in a separate study